Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Legal & IP Issues

Laws, legal actions and rulings impacting intellectual property (IP) rights and corporate issues...

BrightGene Copying Gilead's Remdesivir, Says It Wants to In-License the Anti-Viral

China Files for Patent to Gilead's Remdesivir, the Front-Runner for Coronavirus Treatment

China to Extend Drug Patent Protection to 25 Years, Up from 20

Gilead Loses Patent Fight in China for Pricey Hep C Drug

China Revokes J&J’s Trademark for OneTouch Diabetes Monitoring Products

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital